Related Experiment Videos
Mature monocytic cells enter tissues and engraft
1Division of Hematology, Box 357710, University of Washington, Seattle, WA 98195, USA. hemedoc@u.washington.edu
Summary
Mature monocytic cells, specifically ER-MP20(+) expanded monocyte cells (EMC), are the direct precursors to tissue macrophages. These cells show preferential engraftment and differentiation, suggesting potential for gene therapy applications.
Area of Science:
- Immunology
- Cell Biology
- Hematopoiesis
Background:
- Tissue macrophages are crucial for immune responses and tissue homeostasis.
- Identifying the specific circulating precursor cell is essential for understanding macrophage development and for therapeutic interventions.
Purpose of the Study:
- To pinpoint the immediate circulating precursor cell that differentiates into tissue macrophages.
- To evaluate the potential of these precursor cells for gene therapy applications, particularly for lysosomal storage diseases.
Main Methods:
- Culturing ROSA 26 marrow mononuclear cells with specific growth factors to generate expanded monocyte cells (EMC) at various maturation stages.
- Transplanting immature (ER-MP12(+)) and mature (ER-MP20(+)) EMC subpopulations into irradiated mice.
- Utilizing beta-galactosidase staining, F4/80 antigen expression analysis, and PCR for the neogene to track donor cell engraftment, differentiation, and proliferation in vivo.
Main Results:
- Mature ER-MP20(+) EMC demonstrated preferential engraftment in lung and liver tissues compared to immature EMC or unseparated marrow cells.
- Donor cells were observed in multiple organs, forming clusters and expressing macrophage markers (F4/80) by 7-14 days post-transplantation.
- Quantitative PCR confirmed the superior engraftment of ER-MP20(+) EMC, indicating their role as effective macrophage precursors.
Conclusions:
- A mature monocytic cell population (ER-MP20(+) EMC) is the immediate precursor of tissue macrophages.
- These mature monocytic precursors can be expanded and manipulated in vitro, presenting a promising target for gene therapy strategies, such as for lysosomal storage diseases.